• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DAVOL INC., SUB. C.R. BARD, INC. -1213643 AVITENE; AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DAVOL INC., SUB. C.R. BARD, INC. -1213643 AVITENE; AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED Back to Search Results
Catalog Number 1010020
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code Granuloma (1876)
Date of Event 05/01/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As reported, granuloma was found post-usage of avitene.Based on the information provided, no conclusion can be made as to the extent to which the use of avitene powder may have caused or contributed to the patient's alleged postoperative granulomas.No lot number has been provided; therefore, a review of the manufacturing records is not possible.Note: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
As reported, the patient underwent a procedure with usage of avitene, after which a granuloma was found.Cleaning was performed after placing the avitene and hemostasis achieved.It was reported that the patient is currently being treated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVITENE
Common Device Name
AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED
Manufacturer (Section D)
DAVOL INC., SUB. C.R. BARD, INC. -1213643
100 crossings blvd.
warwick RI 02886
Manufacturer (Section G)
DAVOL INC. -1223089
160 new boston st.
woburn MA 01801
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key22168198
Report Number1213643-2025-00455
Device Sequence Number15757717
Product Code LMF
UDI-Device Identifier00801741000386
UDI-Public(01)00801741000386
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
N17600
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 05/20/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number1010020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/19/2025
Initial Report FDA Received Date06/09/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-